Pivotal Data For The Investigational Treatment PSD502 For Primary Premature Ejaculation
Links shared publicly online about this topic.
- 1,126total visits
Pivotal Data For The Investigational Treatment PSD502 For Primary Premature Ejaculation
View full resource at medicalnewstoday.com
Tags: Drug, Pharma, Shionogi, Sexual Dysfunction
Most Recently Shared on June 1, 2010 at 4:44 pm By:
Pivotal Data For The Investigational Treatment PSD502 For Primary Premature Ejaculation: Shionogi Pharma, Inc., a ... http://mnt.to/f/3DkZ
Also Shared By:
Pivotal Data For The Investigational Treatment PSD502 For Primary Premature Ejaculation In The U.S. To Be Presented At Meeting
medicalnewstoday.com — “Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., presented data summarizing the results of two pivotal studies of the investigational new drug PSD502, a topical metered d” View full resource at medicalnewstoday.com
Most Recently Shared on June 2, 2010 at 4:55 am By:
Urology & Nephrology OW Health
Pivotal Data For The Investigational Treatment PSD502 For Primary Premature Ejaculation In The U.S. To Be Presente... http://mnt.to/f/3DmX
Pivotal data for the investigational treatment PSD502 for primary premature ejaculation
eurekalert.org — “Data summarizing the results of two pivotal studies of the investigational new drug, PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation. These data were presented at the 2010 American Urological Association Annual Meeting in San Francisco.” View full resource at eurekalert.org
Most Recently Shared on June 1, 2010 at 4:34 am By:
AAAS Pivotal data for the investigational treatment PSD502 for primary premature ejaculation http://bit.ly/de8OU3
Advertisement
MNT Erectile Dysfunc
@mnt_ed
Pivotal Data For The Investigational Treatment PSD502 For Primary Premature Ejaculation http://mnt.to/3DkZ #erectiledysfunction
1 year ago...